Notably, it reduced key signs of orbital disease, including brown adipose tissue expansion, CCL5-positive immune cell infiltration, CD4<sup>+</sup> T-cell infiltration and the presence of F4/80<sup>+</sup> macrophages. The gene discussed is CCL5; the disease is disease of orbital part of eye adnexa.